Items where Author is "Serrano-Blanco, Antoni"

Number of items: 5.
  • Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study). Rubio-Valera, Maria and Beneitez, Imma and Peñarrubia-María, María Teresa and Luciano, Juan V. and Mendive, Juan M. and McCrone, Paul and Knapp, Martin and Sabés-Figuera, Ramon and Kocyan, Katarzyna and García-Campayo, Javier and Serrano-Blanco, Antoni
  • Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder:a multisite non-randomized-controlled trial in primary care (INFAP study). Rubio-Valera, Maria and Peñarrubia-María, María Teresa and Iglesias-González, Maria and Knapp, Martin and McCrone, Paul and Roig, Marta and Sabes-Figuera, Ramón and Luciano, Juan V. and Mendive, Juan M. and Murrugara-Centurión, Ana Gabriela and Alonso, Jordi and Serrano-Blanco, Antoni description
  • Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study). Feliu-Soler, Albert and Borràs, Xavier and Peñarrubia-María, María T. and Rozadilla-Sacanell, Antoni and D’Amico, Francesco and Moss-Morris, Rona and Howard, Matthew A. and Fayed, Nicolás and Soriano-Mas, Carles and Puebla-Guedea, Marta and Serrano-Blanco, Antoni and Pérez-Aranda, Adrián and Tuccillo, Raffaele and Luciano, Juan V.
  • Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial. Luciano, Juan V. and D’Amico, Francesco and Cerdà-Lafont, Marta and Peñarrubia-María, María T. and Knapp, Martin and Cuesta-Vargas, Antonio I. and Serrano-Blanco, Antoni and García-Campayo, Javier
  • Cost-utility of group acceptance and commitment therapy for fibromyalgia versus recommended drugs: an economic analysis alongside a 6-month randomised controlled trial conducted in Spain (EFFIGACT study). Luciano, Juan V. and D'Amico, Francesco and Feliu-Soler, Albert and McCracken, Lance M. and Aguado, Jaume and Peñarrubia-María, Maria T. and Knapp, Martin and Serrano-Blanco, Antoni and García-Campayo, Javier